JJ
Z世代の女性から圧倒的支持を得る『JJ』の専属モデルとして大活躍しているかたわら、Netflixリア...
cocotte
Washington (AFP) - The US said Thursday only adults who "have personal concerns" about mRNA vaccines, access issues or medical reasons for refusing them may now receive the Johnson & Johnson Covid shot, which has been linked to a rare but serious clotting condition. The vaccine, which was authorized as a single shot, is less protective than those developed by Pfizer and Moderna, and in December the Centers for Disease Control and Prevention advised the public to steer clear. Thursday's decision by the Food and Drug Administration builds on that recommendation by limiting the J&J vaccine's emer...
AFP
Washington (AFP) - A US government-appointed panel of medical experts on Thursday unanimously recommended mRNA Covid vaccines made by Pfizer and Moderna over Johnson & Johnson's shot, in light of its weaker protection and greater risks. The panel voted 15-0 in favor of the new guidance, which applies to everyone over 18 years of age. Centers for Disease Control and Prevention (CDC) director Rochelle Walensky signed off on the measure Thursday evening. "Today's updated recommendation emphasizes CDC's commitment to provide real-time scientific information to the American public," she said in a ...
AFP
Washington (AFP) - A high level panel of US medical experts voted unanimously Friday to recommend authorizing a second shot of the Johnson & Johnson Covid vaccine. The decision will help end a sense of limbo for 15 million Americans who received the first dose but were worried whether it was enough to protect them, particularly after the rise of the Delta variant. The committee members, convened by the Food and Drug Administration (FDA), agreed with the pharmaceutical company that safety and efficacy evidence favored a second dose. The recommendation may be tweaked further by the FDA and by t...
AFP
Washington (AFP) - Drug maker Johnson & Johnson asked the US Food and Drug Administration (FDA) on Tuesday to authorize booster shots of its Covid-19 vaccine for people over the age of 18. "Our clinical program has found that a booster of our Covid-19 vaccine increases levels of protection for those who have received our single-shot vaccine to 94 percent," said Mathai Mammen, global head of research and development at J&J. J&J said that when a booster was given six months after the first shot, "antibody levels increased nine-fold one week after the booster and continued to climb to 12-fold hig...
AFP
Washington (AFP) - The Johnson & Johnson Covid vaccine is more effective when given as a two-dose regime, according to new data released by the company on Tuesday. A second shot given 56 days after the first provided 75 percent protection against symptomatic Covid in a global clinical trial, with that level rising to 94 percent in the United States. The reason behind this difference was not clear from the company's press release, but it could be linked to fewer variants in the US when the data accrued. It was 94 percent effective in preventing severe or critical Covid at least 14 days post fin...
AFP
At least 44 U.S. state attorneys general and lawyers are believed to disclose a $26 billion settlement proposal to resolve claims that Johnson & Johnson (NYSE:JNJ) and other opioid-distributing companies were partly responsible for a nationwide opioid epidemic. Q2 2021 hedge fund letters, conferences and more A Complex Civil LawsuitAs informed by Fox Business, J&J said it would pay $5 billion, while distributors McKesson Corporation (NYSE:MCK), Cardinal Health Inc (NYSE:CAH), and AmerisourceBergen Corp (NYSE:ABC) are expected to pay a combined $21 billion. More than 40 states are believed to s...
ValueWalk
Washington (AFP) - The US Food and Drug Administration updated its warning labels Monday for the Johnson & Johnson Covid-19 vaccine to include information about an observed "increased risk" of a rare neurological disorder called Guillain-Barre Syndrome (GBS). The news is a further blow for the company, which was granted an emergency use authorization for its shot in February but has played a minor role in America's coronavirus immunization campaign. Based on analysis of a federal vaccine safety monitoring system, officials have identified 100 preliminary reports of GBS after approximately 12.5...
AFP
Washington (AFP) - Johnson & Johnson, one of the pharmaceutical giants accused of fueling the deadly US opioid crisis, has reached a settlement with the state of New York for $230 million and confirmed it will stop making or selling opioids in the United States. The agreement announced Saturday allows Johnson & Johnson to resolve litigation over its role in the epidemic, which has killed more than half a million people since 1999, according to a statement from New York attorney general Letitia James. For its part, in a separate statement J&J said the settlement allowed it to avoid a trial that...
AFP
Washington (AFP) - Johnson & Johnson said Thursday the US Food and Drug Administration had authorized an extension for the shelf life of its Covid-19 vaccine from three months to four-and-a-half months. The news comes as millions of doses of the single-shot vaccine, which is stored at refrigerator temperatures, were in danger of expiring and being tossed. "The decision is based on data from ongoing stability assessment studies," the company said in a statement about the FDA approval. According to data from the Centers for Disease Control and Prevention, 21 million doses of the vaccine have be...
AFP
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら